A group purchasing organization (GPO) is an entity that negotiates bulk discounts on medical supplies, medications, and equipment on behalf of healthcare providers. By pooling the buying power of thousands of hospitals, nursing homes, and clinics, GPOs secure lower prices than any single facility could get on its own. Over 95% of U.S. hospitals use at least one GPO for their purchasing needs.
How GPOs Work
The core idea is simple: volume equals leverage. A single hospital buying surgical gloves or IV pumps has limited negotiating power with a manufacturer. But when a GPO represents hundreds or thousands of hospitals, it can approach that same manufacturer and say, “We’ll guarantee you access to all of these buyers if you lower your price.” The manufacturer agrees because it gets a massive, reliable customer base. The hospitals benefit because they pay less per unit.
GPOs don’t actually buy or distribute products. They negotiate contracts with manufacturers and vendors, then make those contracts available to their member hospitals and clinics. Each facility still places its own orders and works with distributors for delivery. The GPO’s role is purely in securing favorable pricing and contract terms.
The range of products covered is broad. GPOs negotiate contracts for pharmaceuticals, surgical instruments, implantable devices, lab supplies, personal protective equipment, and everyday items like linens and cleaning products. Some GPOs also negotiate service contracts for things like equipment maintenance or consulting.
The Financial Model
GPOs operate on a funding structure that might seem counterintuitive: the vendors, not the hospitals, pay the GPO. When a manufacturer signs a contract through a GPO, it pays the GPO an administrative fee, typically a percentage of total sales made under that contract. According to a U.S. Government Accountability Office review, the most common fee is 3% of the purchase price, though the actual average falls between 1% and 2% when weighted by purchasing volume.
This model raises an obvious question: doesn’t it create a conflict of interest if GPOs are paid by the very companies they’re supposed to negotiate against? Congress addressed this in 1986 by creating a legal safe harbor under the Anti-Kickback statute, which would otherwise prohibit such payments. To qualify for this protection, a GPO must have a written agreement with its member hospitals specifying that fees will be 3% or less (or disclosing the exact amount), and it must report those fees in writing to each member at least annually.
For hospitals, joining a GPO is generally free or low-cost. The value proposition is straightforward: the GPO earns its revenue from vendor fees, and the hospital saves money on supplies without paying membership dues in most arrangements.
How Much Hospitals Actually Save
The savings depend heavily on the size of the GPO. Research published in the Journal of Public Economics found that when a hospital switches from a smaller GPO (at the 25th percentile of scale) to a larger one (75th percentile), it can reduce supply expenses by about 4.8% per patient discharge. For an average hospital, that translates to roughly $85 saved per discharge and over $1.2 million in annual savings on supplies alone.
Even more modest shifts in GPO size matter. A one-standard-deviation increase in a GPO’s scale reduces an average hospital’s supply costs by 2.7%, or about $720,000 per year. These numbers make clear why nearly every hospital in the country participates: even a few percentage points off supply costs adds up to millions over time.
The Major Players
There are roughly 600 GPOs operating in the United States, but the market is heavily concentrated at the top. About 30 of these are large national organizations negotiating major contracts across all product categories. The biggest names include Vizient, Premier, and HealthTrust, which collectively serve thousands of hospitals and health systems nationwide.
Below that tier, regional GPOs like Amerinet and Intalere play an important role for community hospitals and outpatient clinics that may need more localized support or contracts with regional vendors. Some GPOs specialize in specific care settings, such as long-term care facilities, while others focus on particular product categories rather than offering a full catalog. As the Healthcare Supply Chain Association puts it, “If you’ve seen one GPO, you’ve really only seen one GPO,” because they vary so much in size, ownership structure, and services.
Many smaller GPOs give their members access to contracts negotiated by larger national groups while also adding regional vendor agreements on top. This layered approach lets a community hospital benefit from national-scale pricing while still working with local suppliers.
Oversight and Regulation
GPOs operate under the watch of several federal agencies. The HHS Office of Inspector General enforces the Anti-Kickback statute alongside the Department of Justice. The Federal Trade Commission monitors for antitrust violations, ensuring GPOs don’t unfairly lock out competing vendors. The Centers for Medicare and Medicaid Services requires GPOs to report physician ownership and investment interests, a provision added under the Affordable Care Act.
Beyond government oversight, the industry established a voluntary self-regulation body in 2005 called the Healthcare Group Purchasing Industry Initiative (HGPII). Member GPOs commit to written codes of business conduct, complete annual public accountability questionnaires, and share best practices. In 2010, HGPII added an ethics advisory council and a vendor grievance process that routes complaints through the American Arbitration Association, giving manufacturers a formal channel if they believe a GPO’s contracting practices are unfair.
Common Criticisms
Despite their near-universal adoption, GPOs face persistent scrutiny. The vendor-funded fee structure is the most frequent target. Critics argue that GPOs may favor manufacturers willing to pay higher administrative fees over those offering the best product or lowest price to hospitals. Because GPO revenue rises when the purchase price is higher (since fees are a percentage of sales), there’s a structural tension between maximizing GPO income and minimizing hospital costs.
Another concern involves market access for smaller or newer manufacturers. If a GPO has an exclusive or near-exclusive contract with a dominant supplier, it can be difficult for innovative competitors, including makers of lower-cost alternatives like biosimilar drugs, to break into the hospital market. Research in Health Affairs Scholar examined this dynamic specifically with biosimilars, finding that GPOs play a significant role in steering hospital product choices.
Defenders counter that hospitals are free to buy off-contract from any vendor, that GPO contracts are not mandatory, and that the competitive landscape among GPOs themselves gives hospitals alternatives if they’re dissatisfied. The transparency requirements under the safe harbor provision also mean hospitals can see exactly what fees their GPO collects from each vendor.
Why Nearly Every Hospital Uses One
The math is hard to argue with. Hospitals spend enormous sums on supplies, and even small percentage reductions produce six- or seven-figure savings annually. GPOs also reduce the administrative burden of negotiating hundreds of individual vendor contracts. For a mid-sized hospital that might purchase thousands of different products, having pre-negotiated pricing across most categories saves procurement staff significant time.
In practice, many hospitals belong to more than one GPO, using a primary national GPO for most purchasing while supplementing with a regional or specialty GPO for certain categories. This approach lets facilities mix and match contracts to get the best available pricing across their full range of needs. With 98% of hospitals in one recent sample contracting with a GPO for pharmaceutical purchasing alone, these organizations have become a fundamental part of how American healthcare buys what it needs to operate.